Table 1.

Correlations between IGF2BP2 expression and clinicopathologic parameters of 173 GC patients.

Characteristics	No.	IGF2BP2 Expression		χ2	p	ρ †	p
		Low (N = 81)	High (N = 92)
Age		52.44 ± 11.98	58.38 ± 12.57
<60 y	103	60	43	13.36	0.000 ***	0.278	0.000 ***
≥60 y	70	21	49
Gender
Male	116	54	62	0.01	0.919	−0.008	0.920
Female	57	27	30
Tumor location
Proximal	41	17	24	1.843	0.606	0.003	0.967
Middle	41	22	19
Distal	75	36	39
More than 2	16	6	10
Tumor size
<5 cm	71	40	31	4.381	0.036	0.159	0.037 *
≥5 cm	102	41	61
Histologic type
Adenocarcinoma	151	71	80	1.410	0.842	0.014	0.859
Squamous	1	1	0
Signet ring	11	5	6
Mucinous	7	3	4
Undifferentiated	3	1	2
Borrmann classification
Ⅰ	12	6	6	6.169	0.104	0.170	0.026 *
Ⅱ	40	24	16
Ⅲ	102	46	56
Ⅳ	19	5	14
Differentiation
High	2	1	1	0.621	0.733	−0.056	0.464
Moderate	41	17	24
Poor	130	63	67
Depth of invasion
T1	19	13	6	5.283	0.152	0.160	0.035 *
T2	21	11	10
T3	98	44	54
T4	35	13	22
Lymph-node metastasis
N0	48	31	17	8.533	0.036 *	0.191	0.012 *
N1	73	30	43
N2	32	12	20
N3	20	8	12
Distant metastases
M0	131	66	65	2.748	0.097	0.126	0.098
M1	42	15	27
AJCC pTNM
Ⅰ	33	22	11	7.451	0.059	0.184	0.015 *
Ⅱ	62	28	34
Ⅲ	36	16	20
Ⅳ	42	15	27

ρ ^†, Spearman’s rank correlation coefficient. * p < 0.05, *** p < 0.001.